| Cody Russell, MD | |
|
509 Biltmore Ave, Asheville, NC 28801-4601 | |
| (828) 213-1111 | |
| Not Available |
| Full Name | Cody Russell |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 5 Years |
| Location | 509 Biltmore Ave, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083173926 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2021-03371 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Mcdowell Hospital | Marion, NC | Hospital |
| St Lukes Hospital | Columbus, NC | Hospital |
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Coverage Corp | 3072412592 | 364 |
| Henderson County Hospital Corporation | 8123938115 | 177 |
| St. Luke's Hospital Inc | 1254324585 | 16 |
News Archive
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen the chemist Wei Sun (26) as the recipient of its Best Paper Award 2008.
The first survey of consumers who receive subsidized health insurance through the state's Health Connector shows most give it high marks, according to results released yesterday by the Connector Authority. Eighty-six percent of those surveyed said they were pleased with the range of services covered and the quality of care available, and 82 percent had similar feelings about their choice of doctors.
› Verified 7 days ago
| Entity Name | Henderson County Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447444559 PECOS PAC ID: 8123938115 Enrollment ID: O20040611001396 |
News Archive
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen the chemist Wei Sun (26) as the recipient of its Best Paper Award 2008.
The first survey of consumers who receive subsidized health insurance through the state's Health Connector shows most give it high marks, according to results released yesterday by the Connector Authority. Eighty-six percent of those surveyed said they were pleased with the range of services covered and the quality of care available, and 82 percent had similar feelings about their choice of doctors.
› Verified 7 days ago
| Entity Name | St. Luke's Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497944912 PECOS PAC ID: 1254324585 Enrollment ID: O20050103001010 |
News Archive
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen the chemist Wei Sun (26) as the recipient of its Best Paper Award 2008.
The first survey of consumers who receive subsidized health insurance through the state's Health Connector shows most give it high marks, according to results released yesterday by the Connector Authority. Eighty-six percent of those surveyed said they were pleased with the range of services covered and the quality of care available, and 82 percent had similar feelings about their choice of doctors.
› Verified 7 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20100202000365 |
News Archive
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen the chemist Wei Sun (26) as the recipient of its Best Paper Award 2008.
The first survey of consumers who receive subsidized health insurance through the state's Health Connector shows most give it high marks, according to results released yesterday by the Connector Authority. Eighty-six percent of those surveyed said they were pleased with the range of services covered and the quality of care available, and 82 percent had similar feelings about their choice of doctors.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cody Russell, MD 2001 Kingsley Ave, Orange Park, FL 32073-5148 Ph: (904) 639-2000 | Cody Russell, MD 509 Biltmore Ave, Asheville, NC 28801-4601 Ph: (828) 213-1111 |
News Archive
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen the chemist Wei Sun (26) as the recipient of its Best Paper Award 2008.
The first survey of consumers who receive subsidized health insurance through the state's Health Connector shows most give it high marks, according to results released yesterday by the Connector Authority. Eighty-six percent of those surveyed said they were pleased with the range of services covered and the quality of care available, and 82 percent had similar feelings about their choice of doctors.
› Verified 7 days ago
Dr. Elizabeth T Mccarty, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 Patton Ave, Asheville, NC 28806 Phone: 828-620-0876 | |
Terrence W Burt, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 843-237-3378 Fax: 843-237-5073 | |
Dominic Fredrick Tutera, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-257-4472 | |
Krystin Thomas, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1111 | |
Christopher Foster, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1948 Fax: 828-213-1950 | |
Heather E Spencer, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 206 Asheland Ave, Asheville, NC 28801 Phone: 828-210-3809 Fax: 828-210-3735 |